Becoming a substantial holder
Filed with ASX · · 3 pages · English
Neurotech International Ltd. on 6ix
Earlier from Neurotech International
- Change of Director's Interest Notice
- Annual Report (Typeset)
- Notice of Annual General Meeting/Proxy Form
- NTI Doses First Patient in Phase 3 Beyond Harmony ASD Study
- Initial Director's Interest Notice
Later from Neurotech International
- Corporate Presentation
- Ceasing to be a substantial holder
- Quarterly Activities/Appendix 4C Cash Flow Report
- Results of Meeting
Follow Neurotech International into a list and get an email when it puts out news.
Follow Neurotech International